Advanced imaging has been identified as one factor that contributes to the overall rising cost of healthcare in the US. Unnecessary or inappropriate imaging utilization magnifies the cost burden associated with advanced imaging studies like MRIs and PET/CT scans. Though these studies often provide the best clinical information for making a diagnosis or planning treatment, experts suspect that a significant number of unnecessary studies are performed. Determining the rate of unnecessary imaging can help guide both policy-makers and physicians to develop guidelines that would ultimately reduce costs associated with advanced medical imaging.
A recent study by researchers from Brigham and Women's Hospital Department of Radiology adds new data about unnecessary imaging among cancer patients. Atul Shinagare, MD and attending radiologist, Paul B. Shyn, MD reviewed the reports attached to the PET/CT scans of 250 cancer patients and found that 84 of the reports contained a nuclear medicine physician or radiologist's recommendation for additional imaging tests. Further analysis led the researchers to conclude that 43 (approximately half) of those recommendations were unnecessary.
"Our research indicates that imaging specialists can substantially reduce the frequency of recommendations for additional imaging tests in oncologic PET/CT reports without adversely impacting patient outcomes," said Dr. Shinagare.
Other key findings from the study, which will be presented at the American Roentgen Ray Society Annual Meeting, May 4th in Vancouver, Canada, include:
The study's protocols did not call for the authors to specifically investigate the reader motivations behind the additio
|Contact: Bryan Murphy|
Brigham and Women's Hospital